SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016O_02 - Performance of non-invasive tests in the staging of fibrosis in patients with NAFLD: interim results of a prospective multicentre study | Dr. P. EddowesView Slideset
ASArun SanyalMD, MBBSSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016Defining the gold standard in Biomarker Validation in NAFLD | Arun Sanyal, MD, MBBSView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016Quantitative measures of liver health | Grey Everson, MDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016Principles of Biomarker Development | Margery Connelly, PhD, MBAView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016Need for Biomarker Development in Non-Alcoholic Fatty Liver Disease | Eric Lefebvre, MDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016O_06 - Longitudinal changes in FIB-4 and improvement in fibrosis stage with obeticholic acid: A secondary analysis of FLINT Trial | Dr. A. SanyalView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016LiverMultiScan – quantitative MR imaging for NASH | Rajarshi BanerjeeView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016O_05 - Validation of multiparametric MRI in the assessment and staging of non-alcoholic fatty liver disease | Dr. P. EddowesView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016O_04 - Blood-based Protein Biomarkers of NASH | Dr. S. WilliamsView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016NASH and Fibroscan | Raj Vuppalanchi, MDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016Noninvasive imaging methods for assessment of liver damage in NASH | Bachir Taouli, MDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016Methods of MR fat quantification and their pros and cons | Michael Middleton, MD, PhDView Slideset
